Research and Markets (http://www.researchandmarkets.com/research/gvfxph/global_tumor) has announced the addition of the "Global Tumor Ablation Market 2015-2019" report to their offering.

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.

Segmentation by ablation technology and analysis of the tumor ablation market:

  • Radiofrequency
  • Ultrasound
  • Cryotherapy
  • Microwave

The report estimates the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.

Companies Mentioned:

  • AngioDynamics
  • Boston Scientific
  • Ethicon
  • Medtronic
  • Alpinion Medical System
  • BSD Medical
  • Conmed
  • C2 Therapeutics
  • CSA Medical
  • C.R. Bard
  • Chongqing Haifu Medical Technology
  • Esaote
  • EDAP TMS
  • Galil Medical
  • InSightec
  • Misonix
  • Mermaid Medical
  • Monteris

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Cancer statistics

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by ablation technology

PART 09: Market segmentation by cancer types

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

PART 17: Key vendor analysis

For more information visit http://www.researchandmarkets.com/research/gvfxph/global_tumor